This HTML5 document contains 147 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n12http://dx.doi.org/10.1016/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n6http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q39091664
rdf:type
wikibase:Item
schema:description
bài báo khoa học 2014年論文 2014 թվականի օգոստոսի 7-ին հրատարակված գիտական հոդված 2014年论文 tieteellinen artikkeli מאמר מדעי articol științific επιστημονικό άρθρο 2014年论文 vědecký článek мақолаи илмӣ ৭ আগস্ট ২০১৪-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ научна статия wissenschaftlicher Artikel 2014年論文 2014年论文 tudományos cikk artikulong pang-agham наукова стаття, опублікована в серпні 2014 vedecký článok სამეცნიერო სტატია บทความทางวิทยาศาสตร์ bilimsel makale 2014年论文 vetenskaplig artikel artigo científico article scientific artículu científicu espublizáu en 2014 2014年论文 scientific article published on 7 August 2014 vitskapeleg artikkel 2014 nî lūn-bûn scienca artikolo artikel ilmiah 2014年论文 articolo scientifico article científic artikull shkencor 2014年論文 scientific article published on 7 August 2014 article scientifique научни чланак teaduslik artikkel 2014年の論文 2014년 논문 مقالة علمية نشرت في 7 أغسطس 2014 artigo científico artykuł naukowy научни чланак wetenschappelijk artikel artigo científico naučni članak scientific article published on 7 August 2014 vitenskapelig artikkel научная статья artículo científico publicado en 2014 2014年論文 videnskabelig artikel 2014年論文
p:P577
wds:Q39091664-95A4C32B-4E0F-4C77-B0F7-CF6716C1F31D
wdt:P577
2014-08-07T00:00:00Z
p:P407
wds:Q39091664-B6806829-97C0-4D20-8F48-91389A117E05
wdt:P407
wd:Q1860
p:P2093
wds:Q39091664-A1119755-CF7F-4C00-9200-FF1CD157937E wds:Q39091664-9BCFBA59-5439-43BA-A8EE-75058A92FE53 wds:Q39091664-9352E9EC-0F75-4874-B1AA-60D3527B14D8 wds:Q39091664-64BBAE0B-13F8-48E1-AC5E-1F7B9206BAD9 wds:Q39091664-2D2C5FAA-FC29-48B3-B337-0F56D6FD94FB
wdt:P2093
Michael Szarek Rafael Diaz Gregory G Schwartz Laurence Bessac Cheerag Shirodaria
rdfs:label
Effect of alirocumab, a monoclonal antibody to PCSK9, on long-term cardiovascular outcomes following acute coronary syndromes: rationale and design of the ODYSSEY outcomes trial Effect of alirocumab, a monoclonal antibody to PCSK9, on long-term cardiovascular outcomes following acute coronary syndromes: rationale and design of the ODYSSEY outcomes trial Effect of alirocumab, a monoclonal antibody to PCSK9, on long-term cardiovascular outcomes following acute coronary syndromes: rationale and design of the ODYSSEY outcomes trial
skos:prefLabel
Effect of alirocumab, a monoclonal antibody to PCSK9, on long-term cardiovascular outcomes following acute coronary syndromes: rationale and design of the ODYSSEY outcomes trial Effect of alirocumab, a monoclonal antibody to PCSK9, on long-term cardiovascular outcomes following acute coronary syndromes: rationale and design of the ODYSSEY outcomes trial Effect of alirocumab, a monoclonal antibody to PCSK9, on long-term cardiovascular outcomes following acute coronary syndromes: rationale and design of the ODYSSEY outcomes trial
schema:name
Effect of alirocumab, a monoclonal antibody to PCSK9, on long-term cardiovascular outcomes following acute coronary syndromes: rationale and design of the ODYSSEY outcomes trial Effect of alirocumab, a monoclonal antibody to PCSK9, on long-term cardiovascular outcomes following acute coronary syndromes: rationale and design of the ODYSSEY outcomes trial Effect of alirocumab, a monoclonal antibody to PCSK9, on long-term cardiovascular outcomes following acute coronary syndromes: rationale and design of the ODYSSEY outcomes trial
p:P50
wds:Q39091664-51BB9851-880D-422C-BFA2-C5651890B0FE wds:Q39091664-30019F3D-2D9B-4D55-9EB7-9E9A447A1C08 wds:Q39091664-337056B9-05DF-45C7-B804-8AF37FE045DF wds:Q39091664-91F5EB99-C9CC-4D0C-B3A1-247E912747EA wds:Q39091664-932E2E10-3240-4B7E-B28D-270E5964D2CB wds:Q39091664-10B87E1B-79D4-4FCB-9E27-87BE9FABCB17 wds:Q39091664-10FC483D-CDF5-4A7A-9C69-71A94A36168A wds:Q39091664-11CD6E14-88E9-4D3B-9D66-88BD6E44E206 wds:Q39091664-00875574-580A-4FB2-A55E-6BE830F3574F wds:Q39091664-AFC12A11-23AA-485B-8D23-4C43603C6D29 wds:Q39091664-B17D31EC-177F-486C-B5E2-9501686E1D79 wds:Q39091664-A8CE8B5F-BBDE-4BB4-805B-956AC001C36C wds:Q39091664-ABA56D64-FB7D-4154-B0A3-1270FB019638 wds:Q39091664-EB20A605-C954-4F22-AED4-D87FFF2DF1FB wds:Q39091664-F03BC780-AC9C-4A2E-982F-79DD540BDD0C wds:Q39091664-D45F4AA3-7FA6-40BD-AFA7-D2BD2E829997 wds:Q39091664-D7DC1CCE-CAB5-46F4-A3A5-0038E56442A4 wds:Q39091664-E49559C2-F764-48DA-9D2A-CCF046C7A2D5
wdt:P50
wd:Q91304252 wd:Q39525261 wd:Q1587897 wd:Q16027739 wd:Q114427104 wd:Q82060524 wd:Q64684757 wd:Q114292233 wd:Q63101609 wd:Q114427102 wd:Q114427105 wd:Q64858750 wd:Q114427103 wd:Q114427062 wd:Q47264894 wd:Q62914910 wd:Q114427106 wd:Q501318
p:P1476
wds:Q39091664-9F81CF92-AFEF-4A58-BACC-9E49822E4D69
wdt:P1476
Effect of alirocumab, a monoclonal antibody to PCSK9, on long-term cardiovascular outcomes following acute coronary syndromes: rationale and design of the ODYSSEY outcomes trial
p:P304
wds:Q39091664-77126BA5-2F9E-4862-A681-202F47275F6D
wdt:P304
682-689
p:P31
wds:Q39091664-3036423A-FB4F-4623-88D2-83235545E31D
wdt:P31
wd:Q13442814
p:P921
wds:Q39091664-BDAA8490-4BED-4B16-A9F2-4E231EDE0E72 wds:Q39091664-156A590B-E1C0-4337-8807-86D020B46489 wds:Q39091664-4A9D716E-2F59-467C-A848-2444436F5E5A wds:Q39091664-67787C43-9491-40CB-9D61-117B65E94DF3
wdt:P921
wd:Q79460 wd:Q11068 wd:Q422248 wd:Q266018
p:P698
wds:Q39091664-D1141C41-E3E6-4591-82AE-C823A1A7DFFB
wdtn:P698
n6:25440796
wdt:P698
25440796
p:P1433
wds:Q39091664-F3FEF031-1924-46E9-A888-BBF9A8B7738F
wdt:P1433
wd:Q2227156
p:P433
wds:Q39091664-5A88C2E3-7FA0-44B9-A6B1-EB79FA8C5CF3
p:P478
wds:Q39091664-F2DE8FDE-DEB0-4368-91A0-8D736116D842
wdt:P433
5
wdt:P478
168
p:P356
wds:Q39091664-98898BB6-CFA5-4FF7-8718-45120310BAD2
wdtn:P356
n12:J.AHJ.2014.07.028
wdt:P356
10.1016/J.AHJ.2014.07.028
p:P5875
wds:Q39091664-EECC31AB-C3E0-495B-8020-CD467CDF8F0F
wdt:P5875
264559151